Home
About MPE
About myeloma
News
What we do
COVID-19

Welcome to the Myeloma Patients Europe (MPE) website

Myeloma Patients Europe (MPE) is an umbrella organisation of multiple myeloma patient groups and associations from across Europe.

MPE was formed following the recent merger of the European Myeloma Platform and Myeloma Euronet. MPE is registered as a non-profit organisation (AISBL) under Belgium law.

Our Vision

A network of highly efficient, effective and sustainable myeloma patient organisations across Europe

Our Mission

To provide education, information and support to member groups and to advocate at European, national and local levels for the best possible research and equal access to the best possible treatment and care

Become a member

If you are a patient support group and you are interested in becoming a member of Myeloma Patients Europe, apply for membership now!

Latest news

EHA 25 Virtual – Myeloma highlights June 26, 2020
EHA25 Virtual – AL amyloidosis highlights June 25, 2020
Positive results of selinexor, bortezomib, and dexamethasone in myeloma patients who have received one to three prior lines of therapy June 17, 2020
EHA 2020 – Subcutaneous daratumumab shows improved clinical outcomes in AL amyloidosis June 14, 2020
European Commission grants Marketing Authorisation for subcutaneous daratumumab for all approved intravenous daratumumab indications June 5, 2020

© Myeloma Patients Europe 2017

Myeloma Patients Europe AISBL
Avenue Louise 149/24, 1050 Brussels
Belgium

Privacy Policy
Terms & Conditions
Cookies declaration